UGT1A1 gene mutation due to Crigler-Najjar syndrome in Iranian patients: identification of a novel mutation
- PMID: 24286076
- PMCID: PMC3826477
- DOI: 10.1155/2013/342371
UGT1A1 gene mutation due to Crigler-Najjar syndrome in Iranian patients: identification of a novel mutation
Abstract
Crigler-Najjar syndrome (CNS) type I and type II are inherited as autosomal recessive conditions that are caused by mutations in the UGT1A1 gene. We present the analysis of UGT1A1 gene in 12 individuals from three different families. This analysis allowed us to identify one novel mutation, which was not previously described. In this study, three families with clinically diagnosed CNS referred from Khuzestan province, southwest Iran, were screened. After signing the informed consent, peripheral blood samples from the patients and their parents were collected in EDTA-containing tube followed by DNA extraction using a routine phenol-chloroform method. All five coding exons and the flanking intronic regions of the bilirubin-UGT were amplified by polymerase chain reaction (PCR) followed by DNA sequencing by Sanger method. From the first family, a 9-month-old boy was homozygous for a deletion mutation of two adjacent nucleotides including one adenosine (A) and one glutamine (G) between nucleotides 238 and 239 in exon 1 (c.238_240 del AG). In the second family, there were two affected individuals, an 11-year-old girl and a fetus, found to be homozygous for the same mutation. The third family showed a mutation at nucleotide 479 in exon 1 (Val160Glu) that has been reported previously. Molecular analysis can significantly help confirm the diagnosis of CNS, without any need for the liver biopsy, and may help the therapeutic management by ruling out more harmful causes of hyperbilirubinemia.
Figures


Similar articles
-
Role of a homozygous A(TA)₇TAA promoter polymorphism and an exon 1 heterozygous frameshift mutation UGT1A1 in Crigler-Najjar syndrome type II in a Thai neonate.Genet Mol Res. 2013 Sep 4;12(3):3391-7. doi: 10.4238/2013.September.4.5. Genet Mol Res. 2013. PMID: 24065680
-
Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation.Hum Mutat. 2005 Mar;25(3):325. doi: 10.1002/humu.9322. Hum Mutat. 2005. PMID: 15712364
-
Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I.Hepatology. 1992 May;15(5):941-7. doi: 10.1002/hep.1840150531. Hepatology. 1992. PMID: 1568736
-
Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.Hum Mutat. 2000 Oct;16(4):297-306. doi: 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z. Hum Mutat. 2000. PMID: 11013440 Review.
-
[Gilbert disease and type I and II Crigler-Najjar syndrome due to mutations in the same UGT1A1 gene locus].Med Klin (Munich). 2002 Sep 15;97(9):528-32. doi: 10.1007/s00063-002-1180-6. Med Klin (Munich). 2002. PMID: 12371080 Review. German.
References
-
- Lodoso Torrecilla B, Palomo Atance E, Camarena Grande C, et al. Crigler-Najjar syndrome: diagnosis and treatment. Anales de Pediatria. 2006;65(1):73–78. - PubMed
-
- Huang C, Tan N, Yang S, Sung Y, Huang M. Crigler-Najjar syndrome type 2. Journal of the Formosan Medical Association. 2006;105(11):950–953. - PubMed
-
- Torres M, Bruguera M. Crigler-Najjar syndrome. Gastroenterologia y Hepatologia. 2005;28(10):637–640.103.412 - PubMed
-
- Itoh S. Crigler-Najjar syndrome. Ryoikibetsu Shokogun Shirizu. 2001;(33):519–521. - PubMed
-
- Jesic M, Maglajlic S. The Crigler-Najjar syndrome, type I. Therapeutic dilemmas. Srpski Arhiv za Celokupno Lekarstvo. 2000;128(11-12):389–392. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources